+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infection Surveillance Solutions - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 254 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805792

Global Infection Surveillance Solutions Market to Reach US$1.1 Billion by the Year 2026


Infection surveillance systems are deployed to identify infection trends, evaluate and take preventive measures to control them. Infection surveillance systems provide healthcare institutions with accurate information on employee and patient health and surgical databases with real-time monitoring. Hospitals and long-term care facilities are the biggest user groups of infection surveillance systems. Growth in the global market is being driven by a growing number of healthcare-acquired infections (HAIs); continuing advancements and innovations in the industry; and more expenditure on healthcare. The rising number of surgeries, growing healthcare expenditure, and governmental policies for preventing HAIs are also contributing to the growth of the infection surveillance solution segment. Moreover, the ongoing pandemic has also impacted the global market positively, leading to rising demands for these solutions for preventing and monitoring the spread of infections. The ongoing pandemic has enhanced the health IT solution integration for quicker and more effective infection control and prevention and the bulk of these integrations have happened in the hospitals. The pandemic forced governments across the world to adapt to healthcare IT systems and digital technologies, like the Singapore government that adopted a strategy of collecting data of the whole population using surveillance technology in Community Care Facilities (CCFs).

Amid the COVID-19 crisis, the global market for Infection Surveillance Solutions estimated at US$574.9 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2026, growing at a CAGR of 15.8% over the analysis period. Software, one of the segments analyzed in the report, is projected to grow at a 15.1% CAGR to reach US$756.7 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 17% CAGR for the next 7-year period. This segment currently accounts for a 35.3% share of the global Infection Surveillance Solutions market. A tremendous surge in the adoption of customized software for infection surveillance by multiple healthcare facilities is boosting this segment`s growth. The design of most software also includes analysis functions in real-time. The services ensure that the healthcare providers get access to the technical knowledge base, obtain the product team`s support along with acquiring application management skills of the service providing company, the factors that are instrumental behind the growth of the maintenance service and product support segment.

The U.S. Market is Estimated at $203.3 Million in 2022, While China is Forecast to Reach $122.8 Million by 2026


The Infection Surveillance Solutions market in the U.S. is estimated at US$203.3 Million in the year 2022. The country currently accounts for a 35.26% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$122.8 Million in the year 2026 trailing a CAGR of 17.1% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.6% and 15.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.1% CAGR while Rest of European market (as defined in the study) will reach US$86.4 Million by the end of the analysis period. North America leads the market for solutions on infection surveillance due to a growing preference of various healthcare settings for surveillance systems, aided by government initiatives for boosting its adoption. Additionally, the leading market players too, are growing their respective businesses in the developing countries for increasing their presence regionally. The Asia Pacific market is a fast-growing segment due to the increasing awareness and access to advanced healthcare facilities.

Select Competitors (Total 40 Featured):

  • Asolva Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioVigil Healthcare Systems Inc.
  • CenTrak, Inc.
  • Cerner Corporation
  • CKM Healthcare Inc.
  • Ecolab Inc.
  • GOJO Industries, Inc.
  • Harris Healthcare Group
  • IBM Corporation
  • ICNet International Limited
  • Medexter Healthcare GmbH
  • PeraHealth Inc.
  • PointClickCare Corp.
  • Premier International, Inc.
  • RLDatix
  • STANLEY Healthcare
  • Sunquest Information Systems Inc.
  • Vecna Technologies, Inc.
  • VigiLanz Corporation
  • Vitalacy Inc.
  • Vizzia Technologies
  • Wolters Kluwer N.V.

What`s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the digital archives
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • A Prelude to Infection Surveillance Solutions
  • Impact of Covid-19 and a Looming Global Recession
  • The Never-Ending “Race” Between the Virus & Vaccines Continues. Amidst this Chaotic Battle, Where is the World Economy Heading Now & Beyond?
  • Omicron Spreads Panic Worldwide; Omicron Variant Brings Back Memories & Fears of the Worst Part of the 2020 Pandemic
  • South Africa: Omicron’s Origin Location
  • Omicron: Impact on Travel Industry
  • Countries that have Already Detected Omicron Cases
  • Steps taken by the Countries to Prevent Transmission of Omicron Variant
  • Fears of Tourism Industry
  • Industry Response to the Travel Curbs
  • Financial Impact
  • Scientists Seek to Gather More Information on Omicron
  • Pharma Firms Aim to Improve Existing Vaccines to Counter Omicron
  • With IMF Making an Upward Revision of Global GDP for 2021, Companies Are Bullish About an Economic Comeback Despite a Continuing Pandemic
  • A Strong Yet Exceedingly Patchy & Uncertain Recovery Shaped by New Variants Comes Into Play: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • COVID-19 Impact On Infection Surveillance Solutions Market
  • Influencer Market Insights
  • World Market Trajectories
  • Infection Surveillance Solutions - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Global Market Analysis and Prospects
  • Infection Surveillance Solutions Market Witnesses Steady Growth
  • Surveillance Software Holds a Significant Share
  • By Infection Type, UTI Holds a Strong Place
  • Hospitals Account for a Major Share of the Market
  • North America and Europe Hold Major Presence, Asia-Pacific to Witness Fastest Growth
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Prevalence of Infectious Diseases Spurs Demand for Infection Surveillance Solutions
  • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
  • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
  • Rising Incidence of Hospital Acquired Infections (HAIs) Drives Market Growth
  • Mitigating the Risks Associated With Hospital-Acquired Infections
  • Shift to proactive From Reactive
  • Initiatives for Stewardship
  • Report Production
  • Government Measures to Control HAIs Drive Infection Surveillance Solutions Market
  • Rising Prevalence of Respiratory Infections to Drive Need for POC Molecular Diagnostics
  • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
  • Infection Control Software Witnesses Steady Growth
  • Advantages of Infection Control Software
  • Clinical Surveillance Innovation to Spur the Infection Surveillance Solutions Market
  • Rising Need to Reduce Healthcare Costs to Propel Demand for Infection Surveillance Solutions
  • Current & Required Healthcare Spending as % of GDP
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Rapidly Aging World Population & COVID-19 Induced Re-Focus on Aging-In-Place to Drive Demand
  • Aging Population Steps-Up The Burden on Healthcare: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Digitalization of Healthcare and Technological Advancements
  • Digital Health Investments Record Strong Growth in 2020 1H
  • Digital Health Funding (in US$ billion): 2015-1H2020
  • Increasing Complexity of Healthcare Operations to Spur Demand for Infection Surveillance Solutions Market
  • Global Healthcare IT Market (2020): Percentage Breakdown of Spending by Sector
  • The Move to Cloud Gains Momentum
  • Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Market Opportunities
  • Percentage Share Breakdown of Global Deaths Linked to Air Pollution
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 2: World Historic Review for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 3: World 15-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
  • TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 5: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 6: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • TABLE 13: World Recent Past, Current & Future Analysis for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 14: World Historic Review for Long-Term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 15: World 15-Year Perspective for Long-Term Care Facilities by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Active Players in United States
  • TABLE 19: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 20: USA Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 21: USA 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 22: USA Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 23: USA Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 24: USA 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
  • Active Players in Canada
  • TABLE 25: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 26: Canada Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 27: Canada 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 28: Canada Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 29: Canada Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 30: Canada 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Active Players in Japan
  • TABLE 31: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 32: Japan Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 33: Japan 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 34: Japan Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 35: Japan Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 36: Japan 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Active Players in China
  • TABLE 37: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 38: China Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 39: China 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 40: China Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 41: China Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 42: China 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • TABLE 43: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 44: Europe Historic Review for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 45: Europe 15-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
  • TABLE 46: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 47: Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 48: Europe 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 49: Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 50: Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 51: Europe 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
  • Active Players in France
  • TABLE 52: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 53: France Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 54: France 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 55: France Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 56: France Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 57: France 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
  • Active Players in Germany
  • TABLE 58: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 59: Germany Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 60: Germany 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 61: Germany Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 62: Germany Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 63: Germany 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
  • Active Players in Italy
  • TABLE 64: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 65: Italy Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 66: Italy 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 67: Italy Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 68: Italy Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 69: Italy 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Active Players in United Kingdom
  • TABLE 70: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 71: UK Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 72: UK 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 73: UK Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 74: UK Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 75: UK 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
  • Active Players in Rest of Europe
  • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 77: Rest of Europe Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 78: Rest of Europe 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 79: Rest of Europe Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 80: Rest of Europe Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 81: Rest of Europe 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
  • Infection Surveillance Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Active Players in Asia-Pacific
  • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 83: Asia-Pacific Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 84: Asia-Pacific 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 85: Asia-Pacific Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 86: Asia-Pacific Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 87: Asia-Pacific 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
REST OF WORLD
  • Active Players in Rest of World
  • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by Type - Software and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 89: Rest of World Historic Review for Infection Surveillance Solutions by Type - Software and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 90: Rest of World 15-Year Perspective for Infection Surveillance Solutions by Type - Percentage Breakdown of Value Revenues for Software and Services for the Years 2012, 2021 & 2027
  • TABLE 91: Rest of World Recent Past, Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 92: Rest of World Historic Review for Infection Surveillance Solutions by End-Use - Hospitals, Long-Term Care Facilities and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 93: Rest of World 15-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Long-Term Care Facilities and Other End-Uses for the Years 2012, 2021 & 2027
IV. COMPETITION
  • Total Companies Profiled: 40

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Asolva Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioVigil Healthcare Systems Inc.
  • CenTrak, Inc.
  • Cerner Corporation
  • CKM Healthcare Inc.
  • Ecolab Inc.
  • GOJO Industries, Inc.
  • Harris Healthcare Group
  • IBM Corporation
  • ICNet International Limited
  • Medexter Healthcare GmbH
  • PeraHealth Inc.
  • PointClickCare Corp.
  • Premier International, Inc.
  • RLDatix
  • STANLEY Healthcare
  • Sunquest Information Systems Inc.
  • Vecna Technologies, Inc.
  • VigiLanz Corporation
  • Vitalacy Inc.
  • Vizzia Technologies
  • Wolters Kluwer N.V.